We recently published a list of The best and worst Dow stocks for the next 12 months. In this article, let’s take a look where Johnson & Johnson (Nyse: JNJ) is against other better and worse Dow stocks for the next 12 months.
The industrial average of Dow Jones (Djia), or the Dow, is a weighted index for prices that have long been a health barometer of the United States economy. After touching the highs of all time at the end of November 2024, the index corrected almost 7% by 2025 (April 23) and dropped by 12% compared to highs. Really, the correction reflects several unfavorable new features, including the economic uncertainties and the geopolitical tensions that weigh on economic growth. The market is expected to be volatile as trade and other aspects of the North -American Administration Policy Agenda will be reproduced.
In the midst of this volatility, based on the potential of appreciation of the actions price in the next 12 months, we have created a selection of the The best and the worst Dow stocks Of the 30 constituent stocks.
If we analyze its tracked history since 1899, the Dow has fallen by 7% or more in a single day twenty times. Of these, only seven occurred after 2000, and 5.5% decrease on April 5, 2025, does not count as one of these seven, not even in the top twenty historical. So, technically, this correction was not as severe as before. From the post 2000 corrections, the strong decrease when Covid-19 was the most notable: Dow fell by 7.8%, 10%and 12%out of 9, 12 and 16th In March, respectively, he saw more important falls in that year.
That said, the current period is still one of the most confused moments for market participants, even for older agents in the variable income market, which remain uncertain about their estimates for the wider markets, such as the Dow.
In a recent interview, Lauren Goodwin, a New York Life Investment market strategist, emphasized that the fundamental image is cloudy and that investors are still clear in macroeconomic foundations. Despite some positive economic data, the uncertainty of politics limits visibility. As more data is published, it believes that markets enter a sustained period of high volatility between their own resources and fixed revenue.
In these proof times, investors should examine the most critical foundations, preferring Dow actions with results resilience, clear competitive advantages and exposure to long -term secular growth topics. On April 28, Stephanie Link, Hightower Advisors’ main investment strategist, shared his positive perspectives on the stock market in an interview with CNBC. With the main technology companies, consumer companies and financial companies that announce results, it believes that if corporate income is strong, the recent market rebound could continue. Since the beginning of April, the market has been significantly recovered and attributed the manifestation to better benefits than expected and constant corporate performance. Although notable technological names are not cheap in terms of valuation, he considers the recent falls as long -term purchase opportunities.
While the markets may remain volatile in the coming months, the best Dow’s opportunities for the next 12 months should come from actions with a strong pricing power and a boost. Investors should fulfill actions with strong brands, recurring revenue models and competitive pits, which allow them to navigate macro uncertainty. Since the DOW includes large -headed companies in various industries, these stocks could work better during sales.
To identify the best and worst Dow stocks, we started with the 30 constituent stocks of the DJI index. Then we classified these stocks in ascending order based on the average consensus potential of 1 year. In addition, we also include data on coverage funds that keep shakes in these stocks, using the Insider Monkey Monkey’s coverage fund database to provide a deeper view of institutional investors’ trends.
It is important to keep in mind here that the “best” and “worst” terms are strictly referring to the potential for reverse and do not involve strengths or fundamental weaknesses of the underlying companies.
Note: All price data is near the market on April 23.
Why are we interested in the stocks that cover the funds? The reason is simple: our research has shown that we can overcome the market by imitating the best stock options for the best coverage funds. The strategy of our quarterly bulletin selects 14 stocks of small layers and large layers each quarter and has returned 363.5% since May 2014, exceeding its reference point at 208 percentage points (Check out more details here)).
Johnson & Johnson (JNJ) is the best Dow stock for the next 12 months?
A baby smiling with a wide variety of baby care products in the foreground.
Potential in reverse: 9.2%
Market Chief: $ 374 million
Number of coverage fund holders: 98
Johnson & Johnson (NYSE: JNJ) is a healthcare company that develops therapeutic, medical devices and consumer health products. The company is known for its innovation capabilities and thus focuses on health health care segments promoted by high -growth scientific research.
Johnson & Johnson (NYSE: JNJ) recently announced that he will spend about $ 55 million in the United States for the next four years. The pharmaceutical industry is isolated widely from rates so far, but things could change in the coming months. Despite the potential tariffs, the company maintained its EPS orientation from 2025 financial year and modestly increased its income guide, as announced by its first quarter of 2025 on April 15.
A Raymond James analyst said that Q1 results were strong, with better performance in the pharmaceutical segment, which has promoted upward reviews in EPS income estimates. Despite the impact of Sterala’s loss of exclusivity (LOE), the company should testify to a healthier and lowest growth. The analyst also believes that the new orientation is conservative and realizable, but potential rates are still a risk to the pharmaceutical business. Increased the target of the price of shares to $ 164 from $ 162, maintaining higher rating than the grade intact.
Usually jnj 25th In our list of best and worst Dow stocks for the next 12 months. Although we recognize the potential of Dow’s stocks, our conviction lies in the belief that AI actions have a greater promise to obtain higher yields and do it in a shorter period. There is an AI stock that increased since the beginning of 2025, while the popular AI actions lost around 25%. If you are looking for a stock of IA more promising than JNJ but who sells less than five times, see our report on this Ia stock cheap.
